Fedwatch: How Few i...
Health Care: Health Services
Covance Inc. (CVD: NYSE)
$78.88 0.45 | 0.57%
06/18/13 - 04:01 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 94.73M | 132.19M | 68.25M | 175.88M |
| Operating Gains/Losses | -126.00K | 1.14M | 680.00K | -9.59M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -28.54M | -74.12M | 30.51M | -39.21M |
| (Increase) Decrease in Inventories | 10.92M | 8.23M | -2.00M | -12.72M |
| (Increase) Decrease In Other Current Assets | -23.42M | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -1.96M | 2.30M | -2.76M | -5.16M |
| (Decrease) Increase In Other Current Liabilities | -2.32M | 51.25M | 54.30M | -5.07M |
| (Increase) Decrease In Other Working Capital | 19.08M | -28.76M | 2.55M | 3.70M |
| Other Non-Cash Items | 82.50M | 52.18M | 151.52M | 26.95M |
| Net Cash From Continuing Operations | 260.16M | 243.48M | 334.42M | 259.09M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 260.16M | 243.48M | 334.42M | 259.09M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -151.68M | -134.63M | -126.28M | -131.08M |
| Acquisitions | 0.00 | -411.00K | -20.99M | -17.72M |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 1.02M | 192.00K | 47.00K | 29.00K |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -145.98M | -134.85M | -147.22M | -148.77M |
| Issuance of Debt | 0.00 | 0.00 | 100.00M | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 13.77M | 9.32M | 18.82M | 10.68M |
| Repayment of Long-Term Debt | 0.00 | -97.50M | -2.50M | -55.43M |
| Repurchase of Capital Stock | -323.77M | -8.81M | -256.35M | -4.83M |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 290.00M | -5.00M | 35.00M | 0.00 |
| Net Cash From Financing Activities | -20.00M | -101.98M | -105.03M | -49.58M |
| Effect of Exchange Rate Changes | 9.54M | 5.24M | 5.58M | 7.40M |
| Net Change in Cash & Cash Equivalents | 103.72M | 11.88M | 87.75M | 68.14M |
Portfolios with CVD
- Portfolio NameUser Type
- ContributorTechnical Setups for the We...
- ContributorHedge Funds' Favorite Stock...
- Contributor8 Health Care Buys Ahead of...
- ContributorBarron's Insider Purchases ...
- ContributorDebt Free Short Squeeze Opp...
- UserPART 6 JPMorgan 28th Annual...
- UserPat711
- UserStockpickrOne
- UserMMB
- ContributorBarron's Summary 2-28-2009
Latest CVD Headlines from TheStreet
- Covance Not Cooling Off
05.17.13 | 03:05 pm - 5 Health Care Stocks Ready to Break Out 04.09.13 | 11:04 am
- Covance Stock Hits New 52-Week High (CVD) 03.27.13 | 11:03 am
- Covance Stock Hits New 52-Week High (CVD) 03.20.13 | 09:03 am
- Covance Inc. (CVD): Today's Featured Health Services Winner 03.18.13 | 05:03 pm
- Covance Reaches New 52-Week High (CVD) 03.12.13 | 03:03 pm
- 5 Stocks Hedge Funds Love -- and So Should You 02.06.13 | 11:02 am
- TheStreet Ratings Top 10 Rating Changes 12.10.12 | 03:12 pm
- Covance Inc. Stock Upgraded (CVD) 12.06.12 | 04:12 am
- Covance Inc. Stock Downgraded (CVD) 08.01.12 | 05:08 am
Press Releases for CVD
- Covance Expands Singapore Central Laboratory By 50 Percent To Meet Clients' Increased Asia Pacific Focus - PR Newswire 04.16.13 | 01:04 am
- Covance To Present At The Citi 2013 Global Healthcare Conference - PR Newswire 02.22.13 | 04:02 pm
- Covance To Present At The Leerink Swann Global Healthcare Conference - PR Newswire 02.11.13 | 12:02 pm
- Covance To Present At The 31st Annual J. P. Morgan Healthcare Conference - PR Newswire 01.07.13 | 10:01 am
- Covance Receives SFDA GLP Certification For Its Early Development Facility In Shanghai, China - PR Newswire 12.03.12 | 05:12 pm
- Covance Earns CEO Cancer Gold Standard Employer Accreditation - PR Newswire 12.03.12 | 09:12 am
- Covance To Present At The Lazard Capital Markets 9th Annual Healthcare Conference - PR Newswire 11.12.12 | 10:11 am
- Covance And NAFC Sponsor Free Medical Clinic For More Than 1,200 Patients In Dallas, Texas - PR Newswire 10.16.12 | 08:10 am
- Covance To Present At The Morgan Stanley Global Healthcare Conference - PR Newswire 09.07.12 | 05:09 pm
- Covance Appoints Dr. Steve Street To Lead Worldwide Safety Assessment And Pharmaceutical Chemistry Services - PR Newswire 06.18.12 | 08:06 am
Partner Headlines for CVD
- UPDATE: Sterne Agee Resumes Coverage on Covance with Neutral Rating, $76 PT on Current Valuation - Benzinga 06.12.13 | 09:06 am
- Covance Inc. (CVD): Today's Most Compelling Stock Buy - NASDAQ 05.06.13 | 03:05 pm
- Covance Earnings: Everything You Must Know Now - Wall St. Cheat Sheet 05.01.13 | 05:05 am
- Long-Term Deals With Drug Makers Help Icon's Earnings - Investor's Business Daily 03.06.13 | 02:03 pm
- Four European Stocks Worth a Look Now (DLPH, ICLR, IR, LYB) - Benzinga 11.24.12 | 05:11 pm
- Parexel Signs ASR Agreement - Analyst Blog - NASDAQ 09.21.12 | 03:09 pm
- Apple to REPORT Earnings and 1 Stock Analysis to Note - Wall St. Cheat Sheet 07.24.12 | 01:07 pm
- Covance's EPS Meets, Misses on Revs - Analyst Blog - Zacks 05.04.12 | 05:05 pm
- Covance Beats Zacks Estimates - Analyst Blog - Zacks 11.04.11 | 05:11 pm
- Contract Research (CROs): On the Brink of Recovery - Seeking Alpha 04.15.11 | 07:04 am
